Position in TRAW
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$660,438
New position
Shares Held
786,236
first reported quarter
Ownership
5.12%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#2
of 34 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ally Bridge Group (NY) LLC holds $75,058,438 across 22 Biotechnology names. TRAW ranks #22 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NERV |
Minerva Neurosciences, Inc.
|
2,175,802 | $12,075,701 | |
| 2 | PMN |
ProMIS Neurosciences Inc.
|
620,319 | $8,163,398 | |
| 3 | TRAX |
First Tracks Biotherapeutics, Inc.
|
284,287 | $5,719,854 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
16,493 | $4,036,991 | |
| 5 | ASMB |
Assembly Biosciences, Inc.
|
140,000 | $3,847,200 | |
| 6 | WHWK |
Whitehawk Therapeutics, Inc.
|
817,939 | $3,746,160 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
83,300 | $3,384,479 | |
| 8 | CLYM |
Climb Bio, Inc.
|
249,172 | $3,249,202 |
All Filings in TRAW
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $660,438 | 786,236 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||